MedTrace Logo

Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound

NCT02736435 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2018-02-06

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the effectiveness of MR-HIFU for the treatment of uterine fibroids in Northwestern Ontario, which is a rural and remote setting.

Conditions

  • Uterine Leiomyoma

Interventions

DEVICE

Magnetic Resonance Guided High Intensity Focused Ultrasound

Direct treatment of uterine fibroids with MR-HIFU

DRUG

leuprolide acetate for depot suspension

Treatment of uterine fibroids with leuprolide acetate prior to MR-HIFU

Sponsors & Collaborators

  • Thunder Bay Regional Health Research Institute

    lead OTHER

Principal Investigators

  • Naana A Jumah, MD DPhil FRCSC · Northern Ontario School of Medicine, Thunder Bay Regional Research Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2018-01-18
Completion
2018-01-18
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02736435 on ClinicalTrials.gov